245 related articles for article (PubMed ID: 23586612)
1. Decreased expression of GLT-1 in the R6/2 model of Huntington's disease does not worsen disease progression.
Petr GT; Schultheis LA; Hussey KC; Sun Y; Dubinsky JM; Aoki C; Rosenberg PA
Eur J Neurosci; 2013 Aug; 38(3):2477-90. PubMed ID: 23586612
[TBL] [Abstract][Full Text] [Related]
2. Impaired glutamate transport and glutamate-glutamine cycling: downstream effects of the Huntington mutation.
Behrens PF; Franz P; Woodman B; Lindenberg KS; Landwehrmeyer GB
Brain; 2002 Aug; 125(Pt 8):1908-22. PubMed ID: 12135980
[TBL] [Abstract][Full Text] [Related]
3. Up-regulation of GLT1 expression increases glutamate uptake and attenuates the Huntington's disease phenotype in the R6/2 mouse.
Miller BR; Dorner JL; Shou M; Sari Y; Barton SJ; Sengelaub DR; Kennedy RT; Rebec GV
Neuroscience; 2008 Apr; 153(1):329-37. PubMed ID: 18353560
[TBL] [Abstract][Full Text] [Related]
4. Glutamate toxicity in the striatum of the R6/2 Huntington's disease transgenic mice is age-dependent and correlates with decreased levels of glutamate transporters.
Estrada-Sánchez AM; Montiel T; Segovia J; Massieu L
Neurobiol Dis; 2009 Apr; 34(1):78-86. PubMed ID: 19168136
[TBL] [Abstract][Full Text] [Related]
5. N-Acetylcysteine improves mitochondrial function and ameliorates behavioral deficits in the R6/1 mouse model of Huntington's disease.
Wright DJ; Renoir T; Smith ZM; Frazier AE; Francis PS; Thorburn DR; McGee SL; Hannan AJ; Gray LJ
Transl Psychiatry; 2015 Jan; 5(1):e492. PubMed ID: 25562842
[TBL] [Abstract][Full Text] [Related]
6. Impaired glutamate uptake in the R6 Huntington's disease transgenic mice.
Liévens JC; Woodman B; Mahal A; Spasic-Boscovic O; Samuel D; Kerkerian-Le Goff L; Bates GP
Neurobiol Dis; 2001 Oct; 8(5):807-21. PubMed ID: 11592850
[TBL] [Abstract][Full Text] [Related]
7. Palmitoylation and function of glial glutamate transporter-1 is reduced in the YAC128 mouse model of Huntington disease.
Huang K; Kang MH; Askew C; Kang R; Sanders SS; Wan J; Davis NG; Hayden MR
Neurobiol Dis; 2010 Oct; 40(1):207-15. PubMed ID: 20685337
[TBL] [Abstract][Full Text] [Related]
8. Brain Cholesterol Synthesis and Metabolism is Progressively Disturbed in the R6/1 Mouse Model of Huntington's Disease: A Targeted GC-MS/MS Sterol Analysis.
Kreilaus F; Spiro AS; Hannan AJ; Garner B; Jenner AM
J Huntingtons Dis; 2015; 4(4):305-18. PubMed ID: 26639223
[TBL] [Abstract][Full Text] [Related]
9. Deletion of Neuronal GLT-1 in Mice Reveals Its Role in Synaptic Glutamate Homeostasis and Mitochondrial Function.
McNair LF; Andersen JV; Aldana BI; Hohnholt MC; Nissen JD; Sun Y; Fischer KD; Sonnewald U; Nyberg N; Webster SC; Kapur K; Rimmele TS; Barone I; Hawks-Mayer H; Lipton JO; Hodgson NW; Hensch TK; Aoki CJ; Rosenberg PA; Waagepetersen HS
J Neurosci; 2019 Jun; 39(25):4847-4863. PubMed ID: 30926746
[TBL] [Abstract][Full Text] [Related]
10. Huntington's disease pattern of transcriptional dysregulation in the absence of mutant huntingtin is produced by knockout of neuronal GLT-1.
Laprairie RB; Petr GT; Sun Y; Fischer KD; Denovan-Wright EM; Rosenberg PA
Neurochem Int; 2019 Feb; 123():85-94. PubMed ID: 29709465
[TBL] [Abstract][Full Text] [Related]
11. Transient striatal GLT-1 blockade increases EAAC1 expression, glutamate reuptake, and decreases tyrosine hydroxylase phosphorylation at ser(19).
Salvatore MF; Davis RW; Arnold JC; Chotibut T
Exp Neurol; 2012 Apr; 234(2):428-36. PubMed ID: 22285253
[TBL] [Abstract][Full Text] [Related]
12. Hippocampal Synaptic Dysfunction in a Mouse Model of Huntington Disease Is Not Alleviated by Ceftriaxone Treatment.
Wilkie CM; Barnes JR; Benson CM; Brymer KJ; Nafar F; Parsons MP
eNeuro; 2020; 7(3):. PubMed ID: 32354757
[TBL] [Abstract][Full Text] [Related]
13. Up-regulation of GLT1 reverses the deficit in cortically evoked striatal ascorbate efflux in the R6/2 mouse model of Huntington's disease.
Miller BR; Dorner JL; Bunner KD; Gaither TW; Klein EL; Barton SJ; Rebec GV
J Neurochem; 2012 May; 121(4):629-38. PubMed ID: 22332910
[TBL] [Abstract][Full Text] [Related]
14. Complete but not partial inhibition of glutamate transporters exacerbates cortical excitability in the R6/2 mouse model of Huntington's disease.
Estrada-Sánchez AM; Castro D; Portillo-Ortiz K; Jang K; Nedjat-Haiem M; Levine MS; Cepeda C
CNS Neurosci Ther; 2019 Apr; 25(4):509-518. PubMed ID: 30311425
[TBL] [Abstract][Full Text] [Related]
15. Ceftriaxone-induced up-regulation of cortical and striatal GLT1 in the R6/2 model of Huntington's disease.
Sari Y; Prieto AL; Barton SJ; Miller BR; Rebec GV
J Biomed Sci; 2010 Jul; 17(1):62. PubMed ID: 20663216
[TBL] [Abstract][Full Text] [Related]
16. Ceftriaxone regulates glutamate production and vesicular assembly in presynaptic terminals through GLT-1 in APP/PS1 mice.
Fan S; Li L; Xian X; Liu L; Gao J; Li W
Neurobiol Learn Mem; 2021 Sep; 183():107480. PubMed ID: 34153453
[TBL] [Abstract][Full Text] [Related]
17. N-acetylcysteine modulates glutamatergic dysfunction and depressive behavior in Huntington's disease.
Wright DJ; Gray LJ; Finkelstein DI; Crouch PJ; Pow D; Pang TY; Li S; Smith ZM; Francis PS; Renoir T; Hannan AJ
Hum Mol Genet; 2016 Jul; 25(14):2923-2933. PubMed ID: 27179791
[TBL] [Abstract][Full Text] [Related]
18. Expression, pharmacology and functional activity of adenosine A1 receptors in genetic models of Huntington's disease.
Ferrante A; Martire A; Pepponi R; Varani K; Vincenzi F; Ferraro L; Beggiato S; Tebano MT; Popoli P
Neurobiol Dis; 2014 Nov; 71():193-204. PubMed ID: 25132555
[TBL] [Abstract][Full Text] [Related]
19. Differential electrophysiological and morphological alterations of thalamostriatal and corticostriatal projections in the R6/2 mouse model of Huntington's disease.
Parievsky A; Moore C; Kamdjou T; Cepeda C; Meshul CK; Levine MS
Neurobiol Dis; 2017 Dec; 108():29-44. PubMed ID: 28757327
[TBL] [Abstract][Full Text] [Related]
20. Glycolysis inhibition decreases the levels of glutamate transporters and enhances glutamate neurotoxicity in the R6/2 Huntington's disease mice.
Estrada-Sánchez AM; Montiel T; Massieu L
Neurochem Res; 2010 Aug; 35(8):1156-63. PubMed ID: 20401690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
